Table 1.
Cardiovascular drugs prescribed (N) | 203 504 |
Diabetes drugs prescribed (N) | 160 189 |
Sex, N (%) | |
Female | 13 209 (54.7) |
Male | 10 921 (45.3) |
Age group, N (%) | |
20-39 | 3494 (14.5) |
40-55 | 11 307 (46.9) |
56-64 | 9329 (38.7) |
Race/ethnicity, N (%) | |
Hispanic | 6192 (25.7) |
Non-Hispanic white | 11 707 (48.5) |
Non-Hispanic black | 4765 (19.7) |
Non-Hispanic other | 1066 (4.4) |
Missing/unknown | 400 (1.7) |
% of federal poverty level (FPL), N (%) | |
≤138% | 17 829 (73.9) |
>138% | 3668 (15.2) |
Missing/unknown | 2633 (10.9) |
Urbanicity, N (%) | |
Urban | 18 943 (78.5) |
Rural | 2728 (11.3) |
Missing/unknown | 2459 (10.2) |
State of residence, N (%) | |
Medicaid expansion state | 20 325 (84.2) |
Medicaid non-expansion state | 3805 (15.8) |
Insurance status, N (%) | |
Medicaid only | 9560 (39.6) |
Medicare only | 3650 (15.1) |
Private only | 2877 (11.9) |
Multiple types | 1731 (7.2) |
Partially uninsured | 6312 (26.2) |
Newly insured in 2014, N (%) | 5487 (22.7) |
N visits in study, N (%) | |
1-2 | 2241 (9.3) |
3-5 | 4889 (20.3) |
6-9 | 6407 (26.6) |
≥10 | 10 593 (43.9) |
N visits with PCP, N (%) | |
0-2 | 4499 (18.6) |
3-5 | 7044 (29.2) |
6-9 | 6995 (29.0) |
≥10 | 5592 (23.2) |
% of visits with PCP, N (%) | |
≤25% | 2038 (8.4) |
26-50% | 4165 (17.3) |
51-75% | 6736 (27.9) |
75-100% | 11 191 (46.4) |
Charlson comorbidity index, N (%) | |
0-2 | 7255 (30.1) |
3-4 | 6074 (25.2) |
5-7 | 6675 (27.7) |
≥8 | 4126 (17.1) |
Hypertension on problem list, N (%) | 16 595 (68.8) |
Lipid disorder on problem list, N (%) | 16 820 (69.7) |
Notes: FPL=federal poverty level.
PCP=primary care provider.
Charlson comorbidity index calculated from encounter and problem list diagnoses as of December 31, 2013; “enhanced” index used by permission (Mary Charlson, 2017).